Amedisys Inc (AMED) Stake Lowered by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado reduced its holdings in Amedisys Inc (NASDAQ:AMED) by 17.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,678 shares of the health services provider’s stock after selling 1,427 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Amedisys were worth $374,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Amedisys by 0.7% in the 2nd quarter. Vanguard Group Inc. now owns 2,386,046 shares of the health services provider’s stock worth $149,867,000 after acquiring an additional 16,368 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Amedisys by 0.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,124,943 shares of the health services provider’s stock worth $70,658,000 after buying an additional 7,963 shares in the last quarter. Northern Trust Corp lifted its holdings in Amedisys by 2.8% during the 2nd quarter. Northern Trust Corp now owns 804,167 shares of the health services provider’s stock worth $50,510,000 after buying an additional 21,581 shares in the last quarter. TimesSquare Capital Management LLC lifted its holdings in Amedisys by 15.7% during the 2nd quarter. TimesSquare Capital Management LLC now owns 731,670 shares of the health services provider’s stock worth $45,956,000 after buying an additional 99,380 shares in the last quarter. Finally, State Street Corp lifted its holdings in Amedisys by 3.9% during the 2nd quarter. State Street Corp now owns 723,786 shares of the health services provider’s stock worth $45,461,000 after buying an additional 26,888 shares in the last quarter. 94.62% of the stock is currently owned by institutional investors and hedge funds.

Shares of Amedisys Inc (NASDAQ AMED) opened at $57.41 on Wednesday. The company has a market cap of $1,910.64, a price-to-earnings ratio of 26.94, a price-to-earnings-growth ratio of 1.36 and a beta of 0.68. Amedisys Inc has a 1 year low of $38.00 and a 1 year high of $65.91. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16.

Amedisys (NASDAQ:AMED) last issued its earnings results on Tuesday, November 7th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.54 by $0.02. The company had revenue of $380.20 million during the quarter, compared to analysts’ expectations of $384.59 million. Amedisys had a net margin of 2.88% and a return on equity of 14.68%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS. equities research analysts forecast that Amedisys Inc will post 2.23 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Amedisys Inc (AMED) Stake Lowered by Public Employees Retirement Association of Colorado” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://transcriptdaily.com/2017/11/15/amedisys-inc-amed-stake-lowered-by-public-employees-retirement-association-of-colorado.html.

Several research firms have issued reports on AMED. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $70.00 price objective on shares of Amedisys in a report on Friday, November 10th. Robert W. Baird upped their price objective on Amedisys from $50.00 to $60.00 and gave the stock a “neutral” rating in a report on Friday, November 10th. Craig Hallum reaffirmed a “buy” rating and set a $68.00 price objective (up previously from $55.00) on shares of Amedisys in a report on Thursday, November 9th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $62.00 price objective (up previously from $56.00) on shares of Amedisys in a report on Thursday, November 9th. Finally, Benchmark Co. reaffirmed a “hold” rating on shares of Amedisys in a report on Thursday, November 9th. Six analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $61.00.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply